Bionomics News
Dr Ryan has over 30 years of international experience in the pharmaceutical and biotechnology industries where she has held executive roles in management of research and development programs as well as business development and alliance management. Having worked in Australia, the US and Uk with compnaies including Peptech, Roche, Cambridge Antibody Technology and Biota Holdings, throughout her career, she has led many successful fundraising campaigns and licensing initiatives inclusive of a $230M US Government contract. Dr Ryan has an interest in public health and the advancement of science and currently chairs the Advisory Board of the ithree Institute at the University of Technology Sydney (UTS), and was previously a Board Member of the Veski, Diabetes Victoria, TechInSA, and the Diabetes Vaccine Development Centre.
This person is not in the org chart
This person is not in any offices
Bionomics News
Bionomics Limited is a clinical-stage biopharmaceutical company engaged in discovery and development of drug candidates focused on the treatment of central nervous system (CNS) disorders and cancer by using its platform technologies.